Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
Apply
Telomelysin & Pembrolizumab
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step